Literature DB >> 32377899

Histoplasma capsulatum 100-kilodalton antigen: recombinant production, characterization, and evaluation of its possible application in the diagnosis of histoplasmosis.

María A Toscanini1, Daniel González Maglio2,3, Paula Capece4, Gladys Posse4, Cristina A Iovannitti5, Alejandro D Nusblat1, María L Cuestas6.   

Abstract

The goal of the present work was to develop a novel reagent with potential for histoplasmosis diagnosis. For this purpose, the genetic sequence of the 100 kDa protein of Histoplasma capsulatum (Hcp100) was cloned and expressed as a secretory protein in Pichia pastoris. After optimizing the culture conditions and purifying by immobilized metal ion affinity chromatography, the highest yield of Hcp100 reached approximately 1.3 mg/l with > 90% purity in shake flasks using basal salt medium supplemented with casamino acids after 72 h of methanol induction. To investigate its potential for diagnosis, its detection in urine samples using specific polyclonal antibodies as reagent was evaluated by dot blot in 6 patients with progressive disseminated histoplasmosis (PDH), of whom all had AIDS. Antigen was detected in urine from all 6 (100%) PDH patients. Urine samples from a pool of 20 healthy individuals did not react with the anti-Hcp100 antibodies. The dot blot assay performed in this study provides preliminary data of a simple technology that can be performed in medical institutions with limited resources to facilitate the rapid diagnosis of histoplasmosis, particularly the disseminated forms. Hence, use of these assays may provide a rapid diagnostic tool of PDH in endemic areas for histoplasmosis where PDH-related mortality is high, hastening treatment and improving patient survival. Finally, this novel antigen and its specific antibodies may provide an alternative diagnostic reagent to the largely unknown and poorly characterized polysaccharide antigens (HPA, galactomannan, histoplasmin) frequently used in the diagnostic tests. KEY POINTS: Few antigens are used as laboratory tools for the immunodiagnosis of histoplasmosis. P. pastoris was an excellent system for recombinant Hcp100 expression. Maximum expression levels of rHcp100 were achieved in BSM with 1% casamino acids. Dot blot assays with anti-rHcp100 antisera can be successfully used for diagnosing PHD.

Entities:  

Keywords:  Antibodies anti-rHcp100; Casamino acids; Diagnosis; Histoplasma capsulatum; Pichia pastoris; Recombinant Hcp100

Mesh:

Substances:

Year:  2020        PMID: 32377899     DOI: 10.1007/s00253-020-10570-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  18 in total

Review 1.  [Relevant aspects of the Hcp100 molecular marker of Histoplasma capsulatum and its potential therapeutic use in histoplasmosis].

Authors:  Antonio Ernesto González-González; Maria Lucia Taylor; Everardo Curiel-Quesada
Journal:  Rev Iberoam Micol       Date:  2011-10-25       Impact factor: 1.044

Review 2.  Diagnosis and treatment of histoplasmosis in solid organ transplant patients.

Authors:  Kiran Gajurel; Reshika Dhakal; Stan Deresinski
Journal:  Curr Opin Infect Dis       Date:  2018-08       Impact factor: 4.915

3.  Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study.

Authors:  Antoine Adenis; Mathieu Nacher; Matthieu Hanf; Célia Basurko; Julie Dufour; Florence Huber; Christine Aznar; Bernard Carme; Pierre Couppie
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

4.  Sensitivity and Specificity of Histoplasma Antigen Detection by Enzyme Immunoassay.

Authors:  Lauren Cunningham; Audrey Cook; Andrew Hanzlicek; Kenneth Harkin; Joseph Wheat; Carla Goad; Emily Kirsch
Journal:  J Am Anim Hosp Assoc       Date:  2015 Sep-Oct       Impact factor: 1.023

Review 5.  Epidemiology of endemic systemic fungal infections in Latin America.

Authors:  Arnaldo Lopes Colombo; Angela Tobón; Angela Restrepo; Flavio Queiroz-Telles; Marcio Nucci
Journal:  Med Mycol       Date:  2011-05-04       Impact factor: 4.076

6.  Fast protocol for the production of Histoplasma capsulatum antigens for antibody detection in the immunodiagnosis of histoplasmosis.

Authors:  Roseli Santos de Freitas; Camila Mika Kamikawa; Adriana Pardini Vicentini
Journal:  Rev Iberoam Micol       Date:  2017-12-06       Impact factor: 1.044

7.  Use of recombinant gp43 isoforms expressed in Pichia pastoris for diagnosis of paracoccidioidomycosis.

Authors:  K C Carvalho; M C Vallejo; Z P Camargo; R Puccia
Journal:  Clin Vaccine Immunol       Date:  2008-01-30

8.  Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy.

Authors:  Diego H Caceres; Christina M Scheel; Angela M Tobón; Angela Ahlquist Cleveland; Angela Restrepo; Mary E Brandt; Tom Chiller; Beatriz L Gómez
Journal:  Clin Vaccine Immunol       Date:  2014-07-09

9.  Importance of the association of molecular and immunological diagnosis in immunocompetent patient with Histoplasma capsulatum and Cryptoccocus neoformans infection: a case report.

Authors:  Kátia Cristina Dantas; Roseli Santos de Freitas; Roberta Scholz Pinto Garcia; Marcos Vinícius da Silva; Edna Cleide Mendes Muricy; Valdelene Sayuri Kohara; Adriana Pardini Vicentini
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-08-26

Review 10.  Progressive disseminated histoplasmosis: a systematic review on the performance of non-culture-based diagnostic tests.

Authors:  Diego R Falci; Elias R Hoffmann; Diego D Paskulin; Alessandro C Pasqualotto
Journal:  Braz J Infect Dis       Date:  2016-11-19       Impact factor: 3.257

View more
  1 in total

Review 1.  Diagnosis of histoplasmosis: current status and perspectives.

Authors:  María Agustina Toscanini; Alejandro David Nusblat; María Luján Cuestas
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-15       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.